# The Safety and PK Study of Inhaled ICF004 in Healthy Chinese Volunteers

> **NCT07719218** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 73 (estimated)

## Conditions studied

- Interstitial Lung Disease (ILD)
- Healthy Volunteers

## Interventions

- **DRUG:** ICF004
- **DRUG:** Placebo
- **DRUG:** ICF004
- **DRUG:** Pacebo

## Key facts

- **NCT ID:** NCT07719218
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-30
- **Primary completion:** 2029-07-30
- **Final completion:** 2029-07-30
- **Target enrollment:** 73 (ESTIMATED)
- **Last updated:** 2026-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07719218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07719218, "The Safety and PK Study of Inhaled ICF004 in Healthy Chinese Volunteers". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07719218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*